Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sedman

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Journal of the Royal Army Medical Corps|October 11, 2013
Determining the wounding effects of ballistic projectiles to inform future injury models: a systematic reviewJohn Breeze, A J Sedman, G R James, et al.
Journal of Clinical Pharmacology|January 1, 1988
Multiple-dose cimetidine administration does not influence the single-dose pharmacokinetics of quinapril and its active metabolite (CI-928)J J Ferry, A B Cetnarowski, A J Sedman, et al.
Journal of Clinical Pharmacology|October 1, 1995
Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitorL L Radulovic, D D Cilla, E L Posvar, et al.
Clinical Pharmacology and Therapeutics|December 1, 1996
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjectsD D Cilla, L R Whitfield, D M Gibson, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Effect of oral antacids on disposition of intravenous enoxacinD E Nix, M E Lebsack, M Chapelsky, et al.
Journal of Clinical Pharmacology|May 1, 1987
Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928J J Ferry, A M Horvath, A J Sedman, et al.
Journal of Clinical Pharmacology|August 1, 1996
Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjectsE L Posvar, L L Radulovic, D D Cilla, et al.
Journal of Clinical Pharmacology|November 1, 1994
Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humansP A Reece, A J Sedman, S Rose, et al.
Biopharmaceutics & Drug Disposition|August 1, 1996
Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal womenR A Boyd, E A Zegarac, M A Eldon, et al.
Journal of Clinical Pharmacology|April 10, 1999
Effect of troglitazone on the pharmacokinetics of an oral contraceptive agentC M Loi, R Stern, J R Koup, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Journal of the Royal Army Medical Corps|October 11, 2013
Determining the wounding effects of ballistic projectiles to inform future injury models: a systematic reviewJohn Breeze, A J Sedman, G R James, et al.
Journal of Clinical Pharmacology|January 1, 1988
Multiple-dose cimetidine administration does not influence the single-dose pharmacokinetics of quinapril and its active metabolite (CI-928)J J Ferry, A B Cetnarowski, A J Sedman, et al.
Journal of Clinical Pharmacology|October 1, 1995
Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitorL L Radulovic, D D Cilla, E L Posvar, et al.
Clinical Pharmacology and Therapeutics|December 1, 1996
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjectsD D Cilla, L R Whitfield, D M Gibson, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Effect of oral antacids on disposition of intravenous enoxacinD E Nix, M E Lebsack, M Chapelsky, et al.
Journal of Clinical Pharmacology|May 1, 1987
Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928J J Ferry, A M Horvath, A J Sedman, et al.
Journal of Clinical Pharmacology|August 1, 1996
Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjectsE L Posvar, L L Radulovic, D D Cilla, et al.
Journal of Clinical Pharmacology|November 1, 1994
Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humansP A Reece, A J Sedman, S Rose, et al.
Biopharmaceutics & Drug Disposition|August 1, 1996
Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal womenR A Boyd, E A Zegarac, M A Eldon, et al.
Journal of Clinical Pharmacology|April 10, 1999
Effect of troglitazone on the pharmacokinetics of an oral contraceptive agentC M Loi, R Stern, J R Koup, et al.
Pageof 9